期刊文献+

阿托伐他汀在高血压病治疗中的研究进展 被引量:13

原文传递
导出
摘要 原发性高血压是一种遗传异质性疾病,是遗传与环境因素共同作用的结果,当二者作用累积到一定程度时,最终导致基因表达异常及病理性的血压升高[1-3]。高血压病是各种心、脑血管疾病的重要病因和危险因素,它可以影响重要脏器如心、
作者 赵丽丽 罗勇
出处 《中华临床医师杂志(电子版)》 CAS 2011年第9期2672-2674,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献29

  • 1刘承云,万晶晶,杨群芳,戚本玲,彭雯,陈学林.Effects of Atorvastatin on Warfarin-induced Aortic Medial Calcification and Systolic Blood Pressure in Rats[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2008,28(5):535-538. 被引量:7
  • 2杨新华.阿托伐他汀治疗早期肾功能不全高血压[J].医药论坛杂志,2008,29(15):69-70. 被引量:3
  • 3张金盈,张力,厉菁,梁颖.阿托伐他汀增加高血压患者外周血内皮祖细胞数量[J].中华高血压杂志,2008,16(4):307-310. 被引量:14
  • 4Chang-Jiang Ge,Shu-Zheng Lu,Yun-Dai Chen,Xiao-Fan Wu,Shen-Jiang Hu,Ying Ji.Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia[J]. Heart and Vessels . 2008 (2)
  • 5Masaya Sugiyama,Masuo Ohashi,Hiroyuki Takase,Koichi Sato,Ryuzo Ueda,Yasuaki Dohi.Effects of atorvastatin on inflammation and oxidative stress[J]. Heart and Vessels . 2005 (4)
  • 6Asher J,Houston M.Statins and C-reactive protein levels. Clin Hypertens(Greenwich) . 2007
  • 7Paulsen L,Holst LM,Bech JN,et al.Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men. Scandinavian Journal of Clinical and Laboratory Investigation . 2009
  • 8Blanco-Colio LM,Osende JI,Martin-Ventura JL,Tunon J,Egido J.Statins in hypertensive patients:potential explanationsfor the ASCOT-LLA study results. Drugs . 2004
  • 9Cusi D,Bianchi G.A primer on the genetics of hypertension. Kidney International . 1998
  • 10Garbers DL,Dubois SK.The molecular basis of hypertension. Annual Review of Biochemistry . 1999

二级参考文献30

  • 1徐盛开,伏静媛,宁金民,赵毅.阿托伐他汀对高血压患者血管内皮功能的影响[J].高血压杂志,2005,13(7):403-406. 被引量:15
  • 2成威,周胜华,张铭,李旭平.阿托伐他汀对高血压肾病蛋白尿及C-反应蛋白和白介素-6的影响[J].高血压杂志,2005,13(12):767-770. 被引量:43
  • 3郑桂安,吴可贵,万建新.他汀类药物对肾脏疾病非降脂的保护作用[J].高血压杂志,2006,14(2):91-93. 被引量:18
  • 4叶平.他汀类药物在高血压患者中的应用[J].中华老年心脑血管病杂志,2006,8(5):289-291. 被引量:6
  • 5[1]Vasa M,Fichtlscherer S,Adler K,et al.Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease[J].Circulation,2001,103:2885-2890.
  • 6[2]Asahara T,Murohara T,Sullivan A,et al.Isolation of putative endothelial progenitor cells for angiogenesis[J].Science,1997,275:964-967.
  • 7[4]Strazzullo P,Kerry SM,et al.Do statins reduce blood pressure:a meta-analysis of randomized,controlled trials[J].Hypertension,2007,49:792-798.
  • 8[5]Hill JM,Zalos G,Halcox JP,et al.Circulating endothelial progenitor cells,vascular function,and cardiovascular risk[J].N Engl J Med,2003,348:593-600.
  • 9[6]Vasa M,Fichtlscherer S,Aicher A,et al.Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease[J].Circ Res,2001,89:E1-7.
  • 10[7]Dimmeler S,Aicher A,Vasa M,et al.HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway[J].J Clin Invest,2001,108:391-397.

共引文献21

同被引文献110

引证文献13

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部